This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Hawkins (HWKN) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Hawkins (HWKN) delivered earnings and revenue surprises of 36.63% and 0.62%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Element Solutions (ESI) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Element Solutions (ESI) delivered earnings and revenue surprises of 2.86% and 0.18%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
FUL vs. HWKN: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
FUL vs. HWKN: Which Stock Is the Better Value Option?
FUL or HWKN: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
FUL vs. HWKN: Which Stock Is the Better Value Option?
Hawkins (HWKN) Strengthens Water Treatment With Wofford Buy
by Zacks Equity Research
Hawkins (HWKN) acquires Wofford Water Service, strengthening its presence in the southern U.S. and expanding its Water Treatment business in Mississippi.
FUL vs. HWKN: Which Stock Is the Better Value Option?
by Zacks Equity Research
FUL vs. HWKN: Which Stock Is the Better Value Option?
Hawkins (HWKN) Acquires Intercoastal Trading in Maryland
by Zacks Equity Research
Hawkins (HWKN) anticipates that the purchase of Intercostal Trading will be accretive to earnings per share this fiscal year.
Do Options Traders Know Something About Hawkins (HWKN) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Hawkins (HWKN) stock based on the movements in the options market lately.
Hawkins (HWKN) Earnings Lag Estimates in Q4, Revenues Beat
by Zacks Equity Research
Hawkins (HWKN) sees strong growth in the Water Treatment segment in the fiscal fourth quarter.
Arcadia Biosciences (RKDA) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Arcadia Biosciences (RKDA) delivered earnings and revenue surprises of 29.37% and 4.58%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Kinross Gold (KGC) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Kinross Gold (KGC) delivered earnings and revenue surprises of 66.67% and 23.34%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Quaker Chemical (KWR) Q1 Earnings Top Estimates
by Zacks Equity Research
Quaker Chemical (KWR) delivered earnings and revenue surprises of 6.09% and 4.39%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Hawkins (HWKN) Hits 52-Week High: What's Driving the Stock?
by Zacks Equity Research
Hawkins (HWKN) exhibits robust stock performance buoyed by strong earnings, promising growth prospects and strategic expansion in the Water Treatment sector.
Zacks Industry Outlook Highlights PPG Industries, Daqo New Energy, Hawkins and American Vanguard
by Zacks Equity Research
PPG Industries, Daqo New Energy, Hawkins and American Vanguard are part of the Zacks Industry Outlook article.
4 Chemical Specialty Stocks to Gain From Demand Recovery
by Anindya Barman
The Zacks Chemicals Specialty industry is poised to benefit from an uptick in demand across major end-use markets. PPG, DQ, HWKN and AVD are set to gain from self-help actions and demand recovery.
MP Materials (MP) Receives $58.5M for Rare Earth Magnet Facility
by Zacks Equity Research
MP Materials (MP) expects to start the commercial production of finished magnets in late 2025 in its U.S. facility.
Mosaic (MOS) January and February Phosphates & Potash Volume Up
by Zacks Equity Research
Mosaic (MOS) discloses January and February 2024 revenues and sales volume, along with an update on the Riverview facility incident.
Arcadia Biosciences (RKDA) Q4 Earnings Beat Mark, Sales Up Y/Y
by Zacks Equity Research
Arcadia Biosciences (RKDA) reports improved top-line results in the fourth quarter of 2023, which is aided by higher GoodWheat and GLA revenues.
Kronos Worldwide (KRO) Shares Surge 59% in 6 Months: Here's Why
by Zacks Equity Research
Kronos Worldwide (KRO) benefits from an uptick in demand for TiO2, easing pricing pressure and its cost-cutting actions.
Eastman (EMN) Chosen by DOE for Up to $375M Investment
by Zacks Equity Research
Eastman (EMN) announces plans to construct a second molecular recycling facility in Longview, TX.
Taseko (TGB) Inks Deal to Buy Balance Stake in Gibraltar Mine
by Zacks Equity Research
Taseko (TGB) finalizes an agreement that will grant it the full ownership of the Gibraltar mine, the second-largest open-pit copper mine in Canada.
Alamos Gold (AGI) to Boost Capacity With Argonaut Acquisition
by Zacks Equity Research
Alamos Gold (AGI) to buy its peer Argonaut for $325 million to increase its gold production.
Dow (DOW) And DOE Partner on Sustainable EV Battery Production
by Zacks Equity Research
Dow (DOW) invests in the U.S. Gulf Coast facility for carbonate solvent production, supporting EV and energy storage markets and sustainability.
Chemours (CC) Q4 Earnings Beat, Revenue Miss Estimates
by Zacks Equity Research
Chemours (CC) fourth-quarter earnings beat estimates, while sales miss despite growth across TT and TSS segments.
5 Low Leverage Stocks to Buy Buoyed by Optimistic Economic Data
by Aparajita Dutta
The crux of safe investment lies in choosing a company that is not burdened with debt, as a debt-free stock is almost impossible to find. You can buy DCI, ATR, LWAY, HWKN and STNG.